Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Point-of-care testing can support antimicrobial stewardship

Researchers say the integration of point-of-care testing could help identify lower-risk patients in hospitals and subsequently reduce antibiotic use.

PCR machine analysing viral DNA


A nasal sample from each patient was prepared and analysed for viral DNA, using a machine on the ward that provided results within 45 minutes

A project in a Hertfordshire hospital has found that a point-of-care test (POCT) for viral respiratory infections reduced the number of inappropriate hospital admissions and antibiotic prescriptions[1].

Data were collected from 901 patients presenting at the emergency department with suspected viral respiratory infection. A nasal sample from each patient was prepared and analysed for viral DNA, using a machine on the ward that provided results within 45 minutes.

Overall, 507 patients (61%) tested positive for any respiratory viral infection, and 85 of these with normal C-reactive protein (CRP) levels and chest X-ray results were discharged from the emergency department. Of those patients with a positive POCT result and abnormal CRP or X-ray, 90% continued antibiotic treatment, but 52% of those with a normal CRP/X-ray result discontinued antibiotics.

Presenting their study at the European Respiratory Society’s International Congress, held in Paris from 5–19 September, 2018, the researchers concluded that POCTs could help support antimicrobial stewardship and could also prevent the cost of unnecessary hospital admissions and reduce the risk of transmitting viral infections to vulnerable individuals within hospital.

“Clinical judgement will always be required in individual patient decisions regarding antibiotic avoidance and early discharge,” the authors said.

“Integration of POCT into a multifaceted assessment tool can help to rapidly identify a lower risk cohort in which these options may be considered.”

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205658

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • PCR machine analysing viral DNA

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.